 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 L01.280.975.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 0 | 1 | 1 | | 1989 | 0 | 4 | 4 | | 1990 | 0 | 13 | 13 | | 1991 | 0 | 17 | 17 | | 1992 | 0 | 11 | 11 | | 1993 | 0 | 14 | 14 | | 1994 | 0 | 36 | 36 | | 1995 | 0 | 40 | 40 | | 1996 | 0 | 24 | 24 | | 1997 | 0 | 33 | 33 | | 1998 | 0 | 45 | 45 | | 1999 | 0 | 32 | 32 | | 2000 | 0 | 38 | 38 | | 2001 | 0 | 31 | 31 | | 2002 | 0 | 32 | 32 | | 2003 | 1 | 33 | 34 | | 2004 | 0 | 31 | 31 | | 2005 | 0 | 31 | 31 | | 2006 | 0 | 37 | 37 | | 2007 | 0 | 27 | 27 | | 2008 | 0 | 58 | 58 | | 2009 | 0 | 44 | 44 | | 2010 | 0 | 74 | 74 | | 2011 | 0 | 70 | 70 | | 2012 | 0 | 59 | 59 | | 2013 | 1 | 57 | 58 | | 2014 | 0 | 64 | 64 | | 2015 | 0 | 56 | 56 | | 2016 | 0 | 57 | 57 | | 2017 | 0 | 57 | 57 | | 2018 | 0 | 38 | 38 | | 2019 | 0 | 20 | 20 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R, Johnson EN, Levine EA, Cardona K, Votanopoulos KI. Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. J Surg Oncol. 2019 Dec; 120(7):1227-1234.
-
Parker DM, Everett AD, Stabler ME, Leyenaar J, Vricella L, Jacobs JP, Thiessen-Philbrook H, Parikh C, Greenberg JH, Brown JR. The Association Between Cardiac Biomarker NT-proBNP and 30-Day Readmission or Mortality After Pediatric Congenital Heart Surgery. World J Pediatr Congenit Heart Surg. 2019 07; 10(4):446-453.
-
Feeney T, Cassidy M, Tripodis Y, McAneny D, Kavanah M, Sachs T, Tseng JF, Drake FT. Association of Primary Language with Outcomes After Operations Typically Performed to Treat Cancer: Analysis of a Statewide Database. Ann Surg Oncol. 2019 Sep; 26(9):2684-2693.
-
Sadak KT, Szalda D, Lindgren BR, Kinahan KE, Eshelman-Kent D, Schwartz LA, Henderson T, Freyer DR. Transitional care practices, services, and delivery in childhood cancer survivor programs: A survey study of U.S. survivorship providers. Pediatr Blood Cancer. 2019 08; 66(8):e27793.
-
Bao J, Donovan C, Amersi F, Zhang X, Giuliano AE, Chung A. Outcomes in patients with small node-negative invasive breast cancer. Breast J. 2019 07; 25(4):638-643.
-
Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet. 2019 06 15; 393(10189):2404-2415.
-
Garcia-Manero G, Roboz G, Walsh K, Kantarjian H, Ritchie E, Kropf P, O'Connell C, Tibes R, Lunin S, Rosenblat T, Yee K, Stock W, Griffiths E, Mace J, Podoltsev N, Berdeja J, Jabbour E, Issa JJ, Hao Y, Keer HN, Azab M, Savona MR. Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. Lancet Haematol. 2019 Jun; 6(6):e317-e327.
-
Fraser CD, Grimm JC, Zhou X, Lui C, Giuliano K, Suarez-Pierre A, Crawford TC, Magruder JT, Hibino N, Vricella LA. Children's Heart Assessment Tool for Transplantation (CHAT) Score: A Novel Risk Score Predicts Survival After Pediatric Heart Transplantation. World J Pediatr Congenit Heart Surg. 2019 05; 10(3):296-303.
-
Nocon CC, Yesensky J, Ajmani GS, Bhayani MK. Failed larynx preservation and survival in patients with advanced larynx cancer. Am J Otolaryngol. 2019 Jul - Aug; 40(4):542-546.
-
Braunstein SE, London WB, Kreissman SG, Villablanca JG, Davidoff AM, DeSantes K, Castleberry RP, Murray K, Diller L, Matthay K, Cohn SL, Shulkin B, von Allmen D, Parisi MT, Van Ryn C, Park JR, La Quaglia MP, Haas-Kogan DA. Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study. Pediatr Blood Cancer. 2019 07; 66(7):e27736.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|